Physician profile
James E Miller
NPI 1992758148
$4,769.88
in general payments reported to CMS, 2019-2025
9 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,821 · 2020: $56.54 · 2021: $325 · 2022: $1,269 · 2023: $164 · 2024: $1,030 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200 · Travel and Lodging: $98.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.14 |
| Travel and Lodging | $98.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,611.09 | 2019 | |
| Edwards Lifesciences Corporation | $1,383.24 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $612.42 | 2022-2024 | |
| Kls-Martin L.P. | $326.31 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $317.17 | 2021-2022 | |
| Getinge USA Sales, LLC | $234.02 | 2022-2024 | Vasoview Hemopro 2 |
| Artivion, INC. | $233.04 | 2019-2020 | |
| Bard Access Systems, INC. | $33.60 | 2019 | |
| Medtronic, INC. | $18.99 | 2025 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.